Tempus AI (NASDAQ:TEM) Shares Climb 4% – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price traded up 4% during mid-day trading on Wednesday. The company traded as high as $70.15 and last traded at $70.9790. Approximately 1,277,730 shares were traded during trading, a decline of 79% from the average session volume of 6,196,327 shares. The stock had previously closed at $68.22.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. BTIG Research increased their target price on Tempus AI from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. UBS Group started coverage on Tempus AI in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $70.00 target price on the stock. HC Wainwright boosted their price target on shares of Tempus AI from $56.00 to $66.00 and gave the company a “buy” rating in a report on Friday, September 11th. Stifel Nicolaus lowered their price target on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating for the company in a research report on Monday, August 3rd. Finally, Freedom Capital upgraded shares of Tempus AI to a “hold” rating in a research report on Tuesday, June 30th. Eleven analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Tempus AI currently has a consensus rating of “Hold” and an average price target of $71.84.

Tempus AI Stock Performance

The stock has a fifty day moving average price of $66.88 and a two-hundred day moving average price of $56.07. The company has a market cap of $12.42 billion, a P/E ratio of -47.78 and a beta of 3.54. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%. The business had revenue of $382.49 million during the quarter, compared to the consensus estimate of $379.69 million. During the same period in the previous year, the firm posted ($0.22) earnings per share. The business’s revenue was up 21.6% on a year-over-year basis. On average, equities analysts forecast that Tempus AI, Inc. will post -1.38 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tempus AI news, EVP Andrew Polovin sold 2,951 shares of the business’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $75.00, for a total transaction of $221,325.00. Following the sale, the executive vice president directly owned 135,189 shares in the company, valued at approximately $10,139,175. The trade was a 2.14% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric Lefkofsky sold 250,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $77.47, for a total transaction of $19,367,500.00. Following the completion of the sale, the chief executive officer directly owned 100,000 shares of the company’s stock, valued at approximately $7,747,000. This represents a 71.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,280,965 shares of company stock valued at $80,397,564. Corporate insiders own 24.26% of the company’s stock.

Institutional Trading of Tempus AI

Several institutional investors have recently modified their holdings of the company. EMC Capital Management bought a new stake in Tempus AI during the second quarter worth approximately $29,000. Ulland Investment Advisors LLC purchased a new position in shares of Tempus AI during the third quarter valued at $41,000. Eastern Bank acquired a new position in Tempus AI during the third quarter valued at $69,000. Whittier Trust Co. raised its position in Tempus AI by 190.0% during the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock valued at $41,000 after buying an additional 570 shares during the period. Finally, CoreCap Advisors LLC raised its position in Tempus AI by 293.4% during the second quarter. CoreCap Advisors LLC now owns 1,019 shares of the company’s stock valued at $59,000 after buying an additional 760 shares during the period. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI, Inc is a technology company focused on applying artificial intelligence and data analytics to precision medicine. The company develops tools intended to help physicians make more informed treatment decisions by combining clinical information, molecular data and other health-related datasets.

Tempus provides genomic testing and diagnostic services, including sequencing and other molecular tests used primarily in oncology. Its platform also offers data and software solutions designed to support clinical research, pharmaceutical development, patient identification for clinical trials and the development of personalized treatment strategies.

Founded in 2015, Tempus is headquartered in Chicago and primarily serves healthcare providers, researchers and life sciences companies.